# Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

> **NCT03880058** · PHASE1,PHASE2 · COMPLETED · sponsor: **Scarless Laboratories, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Scars

## Interventions

- **DRUG:** SLI-F06
- **DRUG:** Formulation buffer

## Key facts

- **NCT ID:** NCT03880058
- **Lead sponsor:** Scarless Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-03
- **Primary completion:** 2021-05-18
- **Final completion:** 2021-05-18
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880058, "Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03880058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*